SLGL Sol-Gel Technologies Ltd.

NASDAQ
$59.71

Sol-Gel Technologies Ltd. (SLGL) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $1.71 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -23.9% since its last earnings release on August 20, 2026.

Sol-Gel Technologies Beat Consensus Estimates
Thursday, August 20, 2026 · 8:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 8:30 AM ET
Earnings Whisper
-
vs ($1.71)
Rev est $200K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $68.90

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sol-Gel Technologies Ltd.

Sol-Gel is a dermatology company focused on identifying, developing and commercializing or partnering drug products for the treatment of skin diseases.

Sector

Healthcare

Industry

Drugs - Generic

Charts powered in part by Lightweight Charts™ by TradingView.